Načítá se...
Intermittent Administration of Rapamycin Extends the Life Span of Female C57BL/6J Mice
Inhibition of the mTOR (mechanistic target of rapamycin) signaling pathway by the FDA-approved drug rapamycin promotes life span in numerous model organisms and delays age-related disease in mice. However, the utilization of rapamycin as a therapy for age-related diseases will likely prove challengi...
Uloženo v:
| Vydáno v: | J Gerontol A Biol Sci Med Sci |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4906329/ https://ncbi.nlm.nih.gov/pubmed/27091134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/gerona/glw064 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|